Health Condition 1: null- Cervical cancer patients (age 18 years)prescribed treatment with HDR brachytherapy (intra-cavitary)
Conditions
Interventions
Intervention1: 3D UltraSound device: To Image the area that will undergo external beam radiation therapy
Control Intervention1: Results from the clinical and X-Ray/CT-scan/MRI findings: To Image the a
Sponsors
Philips India Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Having been prescribed treatment with radiation therapy including HDR brachytherapy (intra-cavitary
Exclusion criteria
Exclusion criteria: • Stage less than 1 A • Patients who have underwent hysterectomy • Consent not available • Recurrent cases of tumor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the feasibility of visualizing applicator, tumor and relevant organs (uterus, cervix, parametrium, bladder and rectum, sigmoid, etc.) in patients with cervical cancer with intracavitary HDR brachytherapy in 3D ultrasound images using a trans-abdominal probe.Timepoint: 2 Months | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ Find a potential systematic scan protocol for acquiring the 3D volumes that will match the MRI data listed in the GEC-ESTROTimepoint: Two months | — |
Countries
India
Contacts
Public ContactPallavi V
Philips Electronics India Limited
Outcome results
None listed